HealthEquity, Inc. (NASDAQ:HQY) Short Interest Up 39.7% in March

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 5,770,000 shares, an increase of 39.7% from the March 15th total of 4,130,000 shares. Approximately 6.8% of the shares of the company are sold short. Based on an average daily volume of 1,060,000 shares, the days-to-cover ratio is presently 5.4 days.

HealthEquity Trading Up 4.7 %

NASDAQ:HQY traded up $3.93 during trading hours on Wednesday, hitting $87.38. 415,876 shares of the stock were exchanged, compared to its average volume of 768,232. The company has a market capitalization of $7.56 billion, a P/E ratio of 80.17, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. HealthEquity has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company's 50 day moving average is $93.48 and its two-hundred day moving average is $96.44.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on HQY shares. KeyCorp reduced their price target on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Barrington Research reissued an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a report on Friday, April 11th. Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. The Goldman Sachs Group decreased their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research note on Thursday, March 27th. Finally, Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and reduced their price objective for the stock from $120.00 to $115.00 in a report on Tuesday, March 25th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $111.75.

Insider Activity

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares of the company's stock, valued at $4,433,820.30. The trade was a 13.55 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the sale, the director now directly owns 84,969 shares of the company's stock, valued at $6,597,842.85. This represents a 6.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 20,381 shares of company stock valued at $1,781,432 over the last 90 days. 2.20% of the stock is currently owned by company insiders.

Institutional Trading of HealthEquity

A number of institutional investors have recently bought and sold shares of HQY. Wealthfront Advisers LLC bought a new stake in HealthEquity in the fourth quarter valued at about $10,304,089,000. T. Rowe Price Investment Management Inc. bought a new stake in shares of HealthEquity in the 4th quarter valued at about $78,107,000. Norges Bank acquired a new stake in shares of HealthEquity in the 4th quarter valued at approximately $74,701,000. Raymond James Financial Inc. bought a new stake in HealthEquity in the fourth quarter valued at approximately $45,728,000. Finally, Iron Triangle Partners LP acquired a new position in shares of HealthEquity in the 4th quarter valued at $32,202,000. Institutional investors and hedge funds own 99.55% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.